Genmab A/S

NASDAQ: GMAB · Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT

Genmab A/S Balance Sheet Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.86B 14.87B 9.89B 8.96B
Short-Term Investments
11.24B 13.27B 12.43B 10.38B
Long-Term Investments
228M 134M 133M 371M
Other Long-Term Assets
52M 62M 48M 27M
Receivables
6.69B 4.95B 5.71B 3.37B
Inventory
62M 57M -143M n/a
Other Current Assets
n/a n/a n/a 31M
Total Current Assets
27.85B 33.14B 28.38B 22.74B
Property-Plant & Equipment
1.89B 1.64B 1.32B 975M
Goodwill & Intangibles
14.88B 101M 146M 254M
Total Long-Term Assets
17.96B 2.15B 1.9B 1.89B
Total Assets
45.81B 35.29B 30.28B 24.63B
Account Payables
n/a n/a 1.72B 350M
Deferred Revenue
24M 33M 33M 26M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
5.19B 2.39B n/a 860M
Total Current Liabilities
5.31B 2.48B 1.82B 1.57B
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
30M 35M 491M 500M
Total Long-Term Liabilities
3.81B 1.2B 1.01B 863M
Total Liabilities
9.11B 3.68B 2.84B 2.43B
Total Debt
1.03B 770M 597M 425M
Common Stock
66M 66M 66M 66M
Retained Earnings
23.55B 19.02B 14.97B 10.02B
Comprehensive Income
490M 60M 98M 81M
Shareholders Equity
36.7B 31.61B 27.44B 22.2B
Total Investments
11.47B 13.4B 12.56B 10.75B